Cargando…

P11. Developing an immunotherapy strategy for the effective treatment of patients with Non Small Cell Lung Cancer (NSCLC): strategies to evaluate immunity in patients on clinical trials

Detalles Bibliográficos
Autores principales:	Neuberger, M, Paustian, C, Hilton, T, Engel, N, Reu, S, Linder, A, Huber, R, Hatz, R, Winter, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072310/ http://dx.doi.org/10.1186/2051-1426-2-S2-P2

Ejemplares similares

Multispectral imaging and objective assessment of immune-tumor interactions in non-small cell lung cancer
por: Ballesteros-Merino, Carmen, et al.
Publicado: (2015)

Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
por: Hilton, Traci, et al.
Publicado: (2014)

Activation of innate and adaptive immunity as an effective combined strategy for cancer immunotherapy
por: Rakhmilevich, Alexander, et al.
Publicado: (2015)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
por: Sanborn, Rachel, et al.
Publicado: (2015)

P54. Possible role of MDSC for the induction of tumour-specific T cells following LRAST
por: Rose, P, et al.
Publicado: (2014)

P53. Effect of lymphodepletion and tumour on host and reconstituted regulatory T-cells in a model of murine melanoma
por: Kovács, J, et al.
Publicado: (2014)

Novel strategy to monitor apparent tumor-specific T cells in patients with cancer
por: van de Ven, Rieneke, et al.
Publicado: (2013)

P67. Targeted natural killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCT) – clinical application of NK cells activated by heat shock protein 70 (Hsp70)
por: Specht, HM, et al.
Publicado: (2014)

In vivo depletion of CD25+ cells prior to LRAST increases therapeutic efficacy in a murine melanoma model
por: Kovács, Julia R, et al.
Publicado: (2014)

TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial
por: Nemunaitis, John, et al.
Publicado: (2015)

Evaluation of circulating tumor cell gene expression profiles before and following combination immunotherapy for advanced prostate cancer
por: Puri, Sachin, et al.
Publicado: (2014)

Mortality in patients with cirrhosis admitted to the ICU: time to rethink strategies?
por: Vaz, A, et al.
Publicado: (2015)

Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
por: Feng, Zipei, et al.
Publicado: (2014)

Strategies which ensure our patient’s safety
por: Guillaumet, G, et al.
Publicado: (2015)

Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy
por: Molli, Poonam, et al.
Publicado: (2013)

Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?
por: Moliner, L., et al.
Publicado: (2023)

Patient's families in the ICU: describing their strategies to face the situation
por: Borges, KK, et al.
Publicado: (2011)

Initial anticoagulation strategy for extracorporeal cardiopulmonary resuscitation patients
por: Iwashita, Y, et al.
Publicado: (2014)

Immunization strategies to elicit mucosal immune response of HIV
por: Shi, Yinghui
Publicado: (2006)

Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment
por: Andtbacka, Robert HI, et al.
Publicado: (2015)

Do we need a change in transfusion strategy in patients with subarachnoidal hemorrage?
por: Valles Angulo, S, et al.
Publicado: (2015)

An acute multidisciplinary treatment strategy for patients with a hip fracture
por: Mortensen, Claus Rosenby
Publicado: (2012)

Challenges encountered in employing a low tidal volume ventilation strategy in patients at risk of ARDS
por: Fisher, R, et al.
Publicado: (2015)

Immune tolerance: DNA vaccine as strategy in autoimmune diseases
por: Saiah, I Djilali
Publicado: (2004)

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
por: Vasaturo, Angela, et al.
Publicado: (2015)

Challenges and strategies in managing food allergy: a patient and allergist perspective
por: Xu, S, et al.
Publicado: (2010)

Management of hyperglycemia in patients with acute ischemic stroke: comparison of two strategies
por: Azevedo, JRA, et al.
Publicado: (2009)

Setting up strategies: patient inclusion in biobank and genomics research in Europe
por: McCormack, Pauline, et al.
Publicado: (2014)

Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR)
por: Singh, Charu
Publicado: (2014)

Vascular normalization: a strategy to recondition the tumor immune microenvironment
por: Huang, Yuhui, et al.
Publicado: (2013)

Bilevel plus PSV and nitric oxide as an alternative ventilatory strategy in acute respiratory distress syndrome patients
por: Saddy, F, et al.
Publicado: (2007)

Strategies to implement a therapeutic hypothermia program
por: Blosser, S, et al.
Publicado: (2010)

Invasive versus conservative waiting strategy in complicated acute pediatric leukemia patients
por: Olosova, A, et al.
Publicado: (2006)

Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients?
por: Pappalardo, F, et al.
Publicado: (2014)

Strategy of treatment in a patient with acute blunt traumatic thoracic aorta dissection
por: Yurekli, I, et al.
Publicado: (2013)

Tumor response from durvalumab (MEDI4736) + tremelimumab treatment in patients with advanced non-small cell lung cancer (NSCLC) is observed regardless of PD-L1 status
por: Rizvi, Naiyer, et al.
Publicado: (2015)

Tumor hypoxia drives immune suppression and immunotherapy resistance
por: Ai, Midan, et al.
Publicado: (2015)

Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and neck cancer
por: Cohen, Ezra EW, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8jt0jtnj0dlsg5rv0uni9r6tbg